Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jul 18, 2015; 7(14): 1807-1817
Published online Jul 18, 2015. doi: 10.4254/wjh.v7.i14.1807
Published online Jul 18, 2015. doi: 10.4254/wjh.v7.i14.1807
Hepatic metastatic disease in pediatric and adolescent solid tumors
Israel Fernandez-Pineda, John A Sandoval, Andrew M Davidoff, Department of Surgery, St. Jude Children’s Research Hospital, Memphis, TN 38105, United States
Author contributions: Fernandez-Pineda I, Sandoval JA and Davidoff AM designed the editorial article and wrote the manuscript.
Conflict-of-interest statement: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Israel Fernandez-Pineda, MD, Department of Surgery, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States. israel.fernandez-pineda@stjude.org
Telephone: +1-901-5952315 Fax: +1-901-5952207
Received: January 22, 2015
Peer-review started: January 22, 2015
First decision: April 10, 2015
Revised: May 7, 2015
Accepted: May 27, 2015
Article in press: May 28, 2015
Published online: July 18, 2015
Processing time: 183 Days and 9.7 Hours
Peer-review started: January 22, 2015
First decision: April 10, 2015
Revised: May 7, 2015
Accepted: May 27, 2015
Article in press: May 28, 2015
Published online: July 18, 2015
Processing time: 183 Days and 9.7 Hours
Core Tip
Core tip: Management of hepatic metastatic disease in pediatric and adolescent cancer patients is not as well delineated as for adults due to the lower incidence of pediatric malignancies and the higher chemosensitivity of childhood tumors. We review liver involvement by metastatic disease from the main pediatric and adolescent solid tumors focusing on management and treatment options.